-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$35.20111.54% Upside
Arcus Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. has been rated by research analysts at Bank of America Securities, Barclays, Truist Financial, Citigroup, Wedbush in the past 90 days.